SCHEMBL8528905

SCHEMBL8528905

COC(=O)CCC(=O)OCC(Cl)(Cl)Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.56
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 3/20 0.41
HTT P42858 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPT P10636 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CA12 O43570 1/20 0.38
CA14 Q9ULX7 1/20 0.38
RECQL P46063 1/20 0.38
POLB P06746 1/20 0.37
HPGD P15428 1/20 0.37
GAA P10253 2/20 0.36
MGAM O43451 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
ADRA2A P08913 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7439614 0.89 ADRA2A (0.37) TSHRALDH1A1MAPTPOLBGAA
SCHEMBL733969 0.80 ALDH1A1 (0.48) TSHRLMNAALDH1A1HSD17B10MAPT
SCHEMBL4067794 0.80 TSHR (0.33) TSHRALDH1A1MAPTADRA2AADRA1A
SCHEMBL4075547 0.80 LMNA (0.41) TSHRLMNAKDM4EALDH1A1MAPT
SCHEMBL508579 0.79 DGKA (0.41) TSHRKMT2AMEN1LMNAKDM4E
SCHEMBL10105403 0.79 TSHR (0.40) TSHRKMT2AMEN1LMNAALDH1A1
SCHEMBL9521455 0.79 MGAM (0.43) ALDH1A1POLBGAAMGAMSI
SCHEMBL9579525 0.77 ALDH1A1 (0.30) ALDH1A1POLB
SCHEMBL17708270 0.77 TSHR (0.54) TSHRKMT2AMEN1LMNAKDM4E
SCHEMBL26230324 0.77 TSHR (0.54) TSHRKMT2AMEN1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821236-A Tumor treatment with arabinofuranosyl purine derivatives GLAXO WELLCOME INC. (US) 1998-10-13 US disclosed
US-5747472-A ANTICARCINOGENIC AGENTS AND ANTITUMOR AGENTS GLAXO WELLCOME INC. (US) 1998-05-05 US disclosed
EP-0539479-B1 HETEROCYCLIC COMPOUNDS WELLCOME FOUND (GB) 1997-04-16 EP disclosed
US-5492897-A ANTITUMOR AGENTS, AUTOIMMUNE DISEASES BURROUGHS WELLCOME CO. (141) (US) 1996-02-20 US disclosed
EP-0539479-A1 HETEROCYCLIC COMPOUNDS. WELLCOME FOUND (GB) 1993-05-05 EP disclosed
WO-1992001456-A1 HETEROCYCLIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1992-02-06 WO disclosed